Regulatory agencies have highlighted the need to assess physical function as key efficacy endpoints in clinical research involving rheumatic and immunological conditions. Wearable digital health technologies (DHTs) capture these real-world patient-centered outcomes continuously and remotely, increasing the probability of trial success and improving management of these conditions.
Schedule a Meeting Download the Guide
To learn more about opportunities with wearable digital health technologies in Rheumatology and Immunology clinical trials, download our full guide.
Download the Guide
Learn about AbbVie’s approach to addressing unmet needs in drug development in immunological diseases and how their team uses DHTs in clinical trials for better data collection, analysis, and integration into research trials.
Immunotherapies such as CAR-T cell therapy are promising advancements in the treatment of some immunological conditions such as Lupus and Rheumatoid Arthritis, but risk of serious adverse events such as cytokine release syndrome (CRS), neurotoxicity, and sepsis lead to prolonged hospital stays that can increase patient burden and trial costs.
Overcome these barriers with our remote patient monitoring platform and AI-powered risk monitoring. Continuous, remote monitoring of patient vital signs can reduce or eliminate prolonged hospitalization to reduce burden and cost while still prioritizing patient safety.
Download the Solution Sheet
